Pathophysiology of Inborn Immunodeficiencies

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Zurich

About this trial

The pathophysiology of primary immunodeficiencies (PID), which encompass a broad range of different diseases with susceptibility to infection and/or a deregulated inflammatory response, is poorly understood. Available treatments are often not specific for a distinct target and might be associated with side effects. To elucidate pathophysiology of different PIDs, stool, urine, blood, tissue biopsies and/or bone marrow will be collected and analysed for anti-microbial activity and inflammatory response. In a second step, targeted treatment for different PIDs might be developed preclinically and ex vivo according to underlying pathophysiology.

Eligibility criteria

Qualifiers

Clinical diagnosis of an inborn error of immunity (primary immunodeficiency, PID)

Clinically healthy (non-age matched) volunteer

Disqualifiers

exclusion of an inborn error of immunity

secondary immunodeficiency

refusal to enter the study

Trial design

Treatments tested in this trial

  • Diagnostic Test

Treatment groups

300 Participants
are divided into 2 treatment groups

Sponsors and collaborators